News

Primary Headaches Prevalent in MS, Research Reveals

The prevalence of primary headaches — those with no clear cause — is high among patients with multiple sclerosis (MS), a new study suggests. Clinical screening of headache among MS patients could help tailor individualized treatments and ease the impact of the disease for these patients. The study, “…

Study Seeks to Better Understand How MS Affects Memory

A new research project will seek to better understand the biological processes that drive memory problems in people with multiple sclerosis (MS), as a better understanding of these processes may open new avenues for intervention. The four-year study is titled “Neuroimaging of Hippocampally Mediated Memory Dysfunction in…

FDA Approves Shorter Infusion Time for MS Therapy Ocrevus

The U.S. Food and Drug Administration has approved a shorter infusion time of Ocrevus (ocrelizumab) for treating relapsing or primary progressive multiple sclerosis (MS). Infusion refers to the slow delivery of a therapy directly into the bloodstream over a period of time. The decision shortens the twice-yearly infusion…

Stem Cell Transplant Reduces Relapses and Disability in RRMS, Study Suggests

Autologous hematopoietic stem cell transplant (AHSCT) induces a reduction in relapse rate and physical disability in patients with relapsing-remitting multiple sclerosis (RRMS) who respond inadequately to other treatments, a small study suggests. The study, “Selective cognitive dysfunction and physical disability improvement after autologous hematopoietic stem cell transplantation…

MS-Specific Cognitive Rehabilitation Tool Shows Promise in Pilot Study

A multiple sclerosis (MS)-specific computerized cognitive rehabilitation (CR) program led to significant improvements in mental skills among MS patients participating in a recent pilot study. These findings suggest that those with MS, and likely other disorders, might gain the greatest benefits from tailored cognitive tests that are specifically adapted…